Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Allergy, Asthma & Immunology Research ; : 190-194, 2015.
Artículo en Inglés | WPRIM | ID: wpr-80637

RESUMEN

Eosinophils have been reported to modulate T cell responses. Previously, we reported that high-mobility group box 1 protein (HMGB1) played a key role in the pathogenesis of asthma. This study was conducted to test our hypothesis that eosinophils could modulate T cell responses via HMGB1 in the pathogenesis of asthma characterized by eosinophilic airway inflammation. We performed in vitro experiments using eosinophils, dendritic cells (DCs), and CD4+ T cells obtained from a murine model of asthma. The supernatant of the eosinophil culture was found to significantly increase the levels of interleukin (IL)-4 and IL-5 in the supernatant of CD4+ T cells co-cultured with DCs. HMGB1 levels increased in the supernatant of the eosinophil culture stimulated with IL-5. Anti-HMGB1 antibodies significantly attenuated increases of IL-4 and IL-5 levels in the supernatant of CD4+ T cells co-cultured with DCs that were induced by the supernatant of the eosinophil culture. In addition, anti-HMGB1 antibodies significantly attenuated the expressions of activation markers (CD44 and CD69) on CD4+ T cells. Our data suggest that eosinophils modulate CD4+ T cell responses via HMGB1 in the pathogenesis of asthma.


Asunto(s)
Anticuerpos , Asma , Células Dendríticas , Eosinófilos , Proteína HMGB1 , Inflamación , Interleucina-4 , Interleucina-5 , Interleucinas , Linfocitos T
2.
Journal of Korean Medical Science ; : 1435-1442, 2013.
Artículo en Inglés | WPRIM | ID: wpr-212608

RESUMEN

Neuropilin 1 (NP1) is a part of essential receptor complexes mediating both semaphorin3A (SEMA3A) and vascular endothelial growth factor (VEGF) which is one of important mediators involved in the pathogenesis of asthma. Therefore, it is possible that SEMA3A plays a role in the pathogenesis of asthma through attenuation of VEGF-mediated effects. In the present study, we aimed to evaluate expression levels of SEMA3A and NP1 using induced sputum of asthmatics and a murine model of asthma. Firstly, SEMA3A and NP1 expressions in induced sputum of asthmatics and SEMA3A and NP1 expression on bronchoalveolar lavage (BAL) cells and lung homogenates of asthmatic mice were determined. Then we evaluated the immunolocalization of VEGF receptor 1 (VEGFR1), VEGF receptor 2 (VEGFR2), and NP1 expressions on asthmatic mice lung tissue and their subcellular distributions using fibroblast and BEAS2B cell lines. Sputum SEMA3A and NP1 expressions were significantly higher in asthmatics than controls. Similarly, SEMA3A and NP1 expressions on BAL cells and lung homogenates were significantly elevated in asthmatic mice compared to control mice. Immunohistochemical analysis showed that VEGFR1, VEGFR2, and NP1 expressions were also uniformly increased in asthmatic mice. Our observations suggest that SEMA3A and NP1 may play important roles in the pathogenesis of asthma.


Asunto(s)
Animales , Femenino , Masculino , Ratones , Asma/metabolismo , Líquido del Lavado Bronquioalveolar/citología , Línea Celular , Modelos Animales de Enfermedad , Fibroblastos/metabolismo , Regulación de la Expresión Génica , Inmunohistoquímica , Pulmón/metabolismo , Ratones Endogámicos C57BL , Neuropilina-1/genética , Semaforina-3A/genética , Esputo/metabolismo , Receptor 1 de Factores de Crecimiento Endotelial Vascular/metabolismo , Receptor 2 de Factores de Crecimiento Endotelial Vascular/metabolismo
3.
Allergy, Asthma & Immunology Research ; : 309-310, 2012.
Artículo en Inglés | WPRIM | ID: wpr-148480

RESUMEN

Allopurinol is one of the causative drugs that induce fixed drug eruption (FDE). The lymphocyte transformation test (LTT) is a safe and reliable diagnostic procedure for drug allergy, but is reported to be rarely positive in patients with FDE. In the current case, we performed an LTT and successfully confirmed allopurinol as the offending drug. This case report suggests that an LTT should be an optional diagnostic tool for FDE or delayed reaction due to allopurinol.


Asunto(s)
Humanos , Alopurinol , Erupciones por Medicamentos , Hipersensibilidad a las Drogas , Activación de Linfocitos , Linfocitos
4.
Experimental & Molecular Medicine ; : 275-280, 2011.
Artículo en Inglés | WPRIM | ID: wpr-19499

RESUMEN

The role of alveolar macrophages (AMs) in the pathogenesis of asthma is still unknown. The aim of the present study was to investigate the effects of AM in the murine model of asthma. AMs were selectively depleted by liposomes containing clodronate just before allergen challenges, and changes in inflammatory cells and cytokine concentrations in bronchoalveolar lavage (BAL) fluid were measured. AMs were then adoptively transferred to AM-depleted sensitized mice and changes were measured. Phenotypic changes in AMs were evaluated after in vitro allergen stimulation. AM-depletion after sensitization significantly increased the number of eosinophils and lymphocytes and the concentrations of IL-4, IL-5 and GM-CSF in BAL fluid. These changes were significantly ameliorated only by adoptive transfer of unsensitized AMs, not by sensitized AMs. In addition, in vitro allergen stimulation of AMs resulted in their gaining the ability to produce inflammatory cytokines, such as IL-1beta, IL-6 and TNF-alpha, and losing the ability to suppress GM-CSF concentrations in BAL fluid. These findings suggested that AMs worked probably through GM-CSF-dependent mechanisms, although further confirmatory experiments are needed. Our results indicate that the role of AMs in the context of airway inflammation should be re-examined.


Asunto(s)
Animales , Femenino , Ratones , Asma/inmunología , Líquido del Lavado Bronquioalveolar/química , Citocinas/biosíntesis , Modelos Animales de Enfermedad , Inmunización , Inmunomodulación/inmunología , Inflamación/inmunología , Leucocitos/inmunología , Macrófagos Alveolares/inmunología , Ratones Endogámicos C57BL , Ovalbúmina/inmunología
5.
Cancer Research and Treatment ; : 45-49, 2009.
Artículo en Inglés | WPRIM | ID: wpr-17145

RESUMEN

The vast majority of patients with metastatic prostate cancer present with bone metastases and high prostate specific antigen (PSA) level. Rarely, prostate cancer can develop in patients with normal PSA level. Here, we report a patient who presented with a periureteral tumor of unknown primary site that was confirmed as prostate adenocarcinoma after three years with using specific immunohistochemical examination. A 64-year old man was admitted to our hospital with left flank pain associated with masses on the left pelvic cavity with left hydronephrosis. All tumor markers including CEA, CA19-9, and PSA were within the normal range. After an exploratory mass excision and left nephrectomy, the pelvic mass was diagnosed as poorly differentiated carcinoma without specific positive immunohistochemical markers. At that time, we treated him as having a cancer of unknown primary site. After approximately three years later, he revisited the hospital with a complaint of right shoulder pain. A right scapular mass was newly detected with a high serum PSA level (101.7 ng/ml). Tissues from the scapular mass and prostate revealed prostate cancer with positive immunoreactivity for P504S, a new prostate cancer-specific gene. The histological findings were the same as the previous pelvic mass; however, positive staining for PSA was observed only in the prostate mass. This case demonstrates a patient with prostate cancer and negative serological test and tissue staining that turned out to be positive during progression. We suggest the usefulness of newly developed immunohistochemical markers such as P504S to determine the specific primary site of metastatic poorly differentiated adenocarcinoma in men.


Asunto(s)
Humanos , Masculino , Adenocarcinoma , Dolor en el Flanco , Hidronefrosis , Metástasis de la Neoplasia , Nefrectomía , Próstata , Antígeno Prostático Específico , Neoplasias de la Próstata , Valores de Referencia , Pruebas Serológicas , Dolor de Hombro , Biomarcadores de Tumor
6.
Korean Circulation Journal ; : 432-435, 2008.
Artículo en Inglés | WPRIM | ID: wpr-203733

RESUMEN

In-stent atheromatous plaque rupture is a very rare event. A 51-year-old man presented with an acute inferior myocardial infarction 9 years after bare-metal stent implantation in the mid-portion of right coronary artery. After thrombolytic therapy, coronary angiography and intravascular ultrasound (IVUS) revealed a ruptured plaque at the mid portion of the stented segment.


Asunto(s)
Humanos , Persona de Mediana Edad , Angiografía Coronaria , Vasos Coronarios , Infarto de la Pared Inferior del Miocardio , Infarto del Miocardio , Placa Aterosclerótica , Rotura , Stents , Terapia Trombolítica , Ultrasonografía Intervencional
7.
The Journal of the Korean Rheumatism Association ; : 154-159, 2007.
Artículo en Coreano | WPRIM | ID: wpr-216851

RESUMEN

Adult onset Still's disease (AOSD) is a systemic inflammatory disorder of unknown etiology and pathogenesis. It is characterized by spiking fever, evanescent skin rash, arthralgia or arthritis, hepatosplenomegaly and laboratory abnormalities including neutrophilic leukocytosis, abnormal liver function tests and raised levels of serum ferritin. Coagulation abnormality is a rare presenting feature but it might be life threatening when associated with hepatopathy and hematologic abnormalities. We report two cases of AOSD with disseminated intravascular coagulation and multiple organ involvement, which improved with glucocorticoid and cyclosporine combination therapy.


Asunto(s)
Adulto , Humanos , Artralgia , Artritis , Ciclosporina , Coagulación Intravascular Diseminada , Exantema , Ferritinas , Fiebre , Leucocitosis , Pruebas de Función Hepática , Insuficiencia Multiorgánica , Neutrófilos , Enfermedad de Still del Adulto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA